# Flow Rate Impact on Arterial Carbon Dioxide During THRIVE

> **NCT05234424** · NA · TERMINATED · sponsor: **Uppsala University Hospital** · enrollment: 1 (actual)

## Conditions studied

- Apneic Oxygenation

## Interventions

- **OTHER:** THRIVE

## Key facts

- **NCT ID:** NCT05234424
- **Lead sponsor:** Uppsala University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-02-08
- **Primary completion:** 2024-05-13
- **Final completion:** 2024-05-13
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Futility. Inclusion and logistics of study in a clinical situation proved too difficult to continue.
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05234424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05234424, "Flow Rate Impact on Arterial Carbon Dioxide During THRIVE". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT05234424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*